Works by Adkins, Jonathan


Results: 13
    1
    2
    3
    4
    5
    6
    7
    8

    Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.

    Published in:
    Veterinary & Comparative Oncology, 2024, v. 22, n. 1, p. 30, doi. 10.1111/vco.12944
    By:
    • Sakthikumar, Sharadha;
    • Warrier, Manisha;
    • Whitley, Derick;
    • Facista, Salvatore;
    • Adkins, Jonathan;
    • Aman, Sara;
    • Tsinajinnie, Darwin;
    • Duran, Natalie;
    • Siravegna, Giulia;
    • Ahmed, Zeeshan;
    • Day, Kenneth;
    • Jenkins, Brooklyn;
    • Patel, Nidhi;
    • Ryden, Kirk;
    • Nadai, Joe;
    • Banovich, Kathryn;
    • Powers, Barbara;
    • Edwards, Jeffrey;
    • Steinberg, Jennifer;
    • Fielder, Susan
    Publication type:
    Article
    9

    A somatic reference standard for cancer genome sequencing.

    Published in:
    Scientific Reports, 2016, p. 24607, doi. 10.1038/srep24607
    By:
    • Craig, David W.;
    • Nasser, Sara;
    • Corbett, Richard;
    • Chan, Simon K.;
    • Murray, Lisa;
    • Legendre, Christophe;
    • Tembe, Waibhav;
    • Adkins, Jonathan;
    • Kim, Nancy;
    • Wong, Shukmei;
    • Baker, Angela;
    • Enriquez, Daniel;
    • Pond, Stephanie;
    • Pleasance, Erin;
    • Mungall, Andrew J.;
    • Moore, Richard A.;
    • McDaniel, Timothy;
    • Ma, Yussanne;
    • Jones, Steven J. M.;
    • Marra, Marco A.
    Publication type:
    Article
    10

    P4‐495: SINGLE NUCLEI AND SINGLE WHOLE CELL SEQUENCING OF ALZHEIMER'S DISEASE.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1503, doi. 10.1016/j.jalz.2019.08.041
    By:
    • Enriquez, Daniel;
    • Elyaderani, Amir;
    • Antone, Jerry;
    • Geiger, Philipp;
    • Adkins, Jonathan;
    • Serrano, Geidy E.;
    • Mastroeni, Diego f;
    • Beach, Thomas G.;
    • Readhead, Benjamin;
    • Dudley, Joel;
    • Reiman, Eric M.;
    • Liang, Winnie
    Publication type:
    Article
    11
    12

    Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.

    Published in:
    PLoS ONE, 2019, v. 14, n. 12, p. N.PAG, doi. 10.1371/journal.pone.0219724
    By:
    • Berens, Michael E.;
    • Sood, Anup;
    • Barnholtz-Sloan, Jill S.;
    • Graf, John F.;
    • Cho, Sanghee;
    • Kim, Seungchan;
    • Kiefer, Jeffrey;
    • Byron, Sara A.;
    • Halperin, Rebecca F.;
    • Nasser, Sara;
    • Adkins, Jonathan;
    • Cuyugan, Lori;
    • Devine, Karen;
    • Ostrom, Quinn;
    • Couce, Marta;
    • Wolansky, Leo;
    • McDonough, Elizabeth;
    • Schyberg, Shannon;
    • Dinn, Sean;
    • Sloan, Andrew E.
    Publication type:
    Article
    13

    E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
    By:
    • Babiker, Hani M.;
    • Byron, Sara A.;
    • Hendricks, William P. D.;
    • Elmquist, William F.;
    • Gampa, Gautham;
    • Vondrak, Jessica;
    • Aldrich, Jessica;
    • Cuyugan, Lori;
    • Adkins, Jonathan;
    • De Luca, Valerie;
    • Tibes, Raoul;
    • Borad, Mitesh J.;
    • Marceau, Katie;
    • Myers, Thomas J.;
    • Paradiso, Linda J.;
    • Liang, Winnie S.;
    • Korn, Ronald L.;
    • Cridebring, Derek;
    • Von Hoff, Daniel D.;
    • Carpten, John D.
    Publication type:
    Article